All updates
All updates
today 30中文产业新闻精选Chinese source评分6565 文献与产业新闻精选评分6363 STAT+: HHS unveils new initiatives to reduce animal testing in drug development
文献与产业新闻精选评分5656 Tariff guidance leaves companies in the dark
文献与产业新闻评分2727 STAT+: Did the Trump administration just cut Novo a huge financial win?
文献与产业新闻评分2121 STAT+: Novo may be getting a better deal than expected with Medicare’s Bridge program
文献与产业新闻评分2121 New federal autism committee head has financial ties to leucovorin
文献与产业新闻评分2121 Funding opportunity launched to strengthen UK regulatory science and support healthcare innovation
文献与产业新闻评分2121 STAT+: Why an influential GOP health policy expert still backs the Medicaid cuts — and which policy target is next
文献与产业新闻精选评分5959 Cordis’ sirolimus drug-coated balloon earns FDA approval as a breakthrough device
中文产业新闻精选Chinese source评分6464 FDA批准基因疗法FAYUVI用于治疗黏多糖贮积症IIIA型，定价395万美元
中文产业新闻精选Chinese source评分7070 FDA 批准 Ionis 反义寡核苷酸药物 Zanvastro (zilganersen) 上市，为首个亚历山大病疗法
文献与产业新闻评分3333 STAT+: Members of Congress push back on plan to create a commission of political appointees to review NIH grants
文献与产业新闻评分3131 STAT+: What a vote on Grail’s cancer detection test could mean for the company, patients, and regulators
文献与产业新闻精选评分4343 STAT+: Lilly’s breast cancer combo wins approval
文献与产业新闻评分1818 Trump calls for some childhood vaccines be split into smaller doses
文献与产业新闻精选评分5252 PDUFA VIII aims to remove CMC bottlenecks, shore up FDA staffing
文献与产业新闻评分2020 President Trump’s newest vaccine ‘demands’ repeat old misinformation
文献与产业新闻精选评分5050 IntraBio's Aqneursa scores expansion, now the first treatment for rare ataxia
文献与产业新闻精选评分4545 White House plans to put NIH grants under political control: reports
文献与产业新闻评分2828 China targets 25% share of global first-in-class drugs in new 5-year plan
FDA Press Releases精选评分5454 FDA Updates Regulations to Advance Innovative Alternatives to Animal Testing
中文产业新闻精选Chinese source评分6060 苏州中化药品维乐宁®（沙库巴曲缬沙坦钠片100mg）获NMPA批准上市
中文产业新闻精选Chinese source评分6565 FDA批准非奈利酮用于1型糖尿病相关慢性肾脏病
中文产业新闻精选Chinese source评分6161 恩沃利单抗联合GEMOX方案获2026版CSCO胆道癌指南Ⅰ级推荐
中文产业新闻精选Chinese source评分6262 Ultragenyx 基因疗法 FAYUVI 获 FDA 批准用于 MPS IIIA，定价 395 万美元
中文产业新闻精选Chinese source评分6565 国家医保局联合卫健委发文支持干细胞药物纳入医保支付
中文产业新闻精选Chinese source评分7070 拜耳非奈利酮获FDA批准用于1型糖尿病相关慢性肾脏病，系30余年来该领域首个新疗法
文献与产业新闻评分4848 STAT+: Trump touts pharma deals to offer cheaper drugs to state Medicaid programs
文献与产业新闻精选评分6969 Ultragenyx wins first approval for MPS IIIA, closing a bumpy four-year path
文献与产业新闻精选评分5757 EMA’s CHMP backs eight new medicines in September
文献与产业新闻精选评分5656 Eli Lilly escalates oral SERD battle with FDA approval for Inluriyo, Verzenio combo
文献与产业新闻评分2020 STAT+: Pharmalittle: We’re reading about licensing deals with China, making drugs in space, and more
文献与产业新闻评分1616 Who supports policies for ‘health equity’? It depends on how you’re asking
文献与产业新闻评分4242 Medtronic earns FDA clearance for LigaSure use with its Hugo robotic system
文献与产业新闻评分2323 FDA clears Aptitude’s latest Metrix molecular dx to test for COVID
中文产业新闻精选Chinese source评分6060 亚盛医药利沙托克拉拟纳入突破性疗法，联合阿可替尼一线治疗 CLL/SLL
中文产业新闻精选Chinese source评分6565 礼来 RET 抑制剂塞普替尼片在中国获批上市
中文产业新闻精选Chinese source评分6060 TACE联合'双艾'方案纳入CSCO原发性肝癌指南2026版I级推荐
中文产业新闻精选Chinese source评分6565 FDA批准拜耳非奈利酮扩展至1型糖尿病肾病
中文产业新闻精选Chinese source评分6565 礼来塞普替尼片剂在中国获批